18F-P-238

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Name18F-P-238
Drug Alias NameFluorine-18-P-23818F-P-238P-238-[F-18]
ClassificationRadiation-emitting productsSmall moleculesDiagnostic agent (In vivo)
Mechanisms of ActionProstate-Specific Membrane Antigen inhibitors
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSiemens Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSiemens Ag
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A